Actively Recruiting
The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis
Led by Linkoeping University · Updated on 2024-08-30
280
Participants Needed
2
Research Sites
278 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this observational study is to learn about how the blood leucocytes from patients with and without exposure or disease from tuberculosis (TB) are able to kill live mycobacteria (M. tuberculosis). The main question it aims to answer is: Is intracellular growth suppression of M. tuberculosis in peripheral blood mononuclear cells variable among healthy blood donors and higher than in patients with latent TB compared to active TB?
CONDITIONS
Official Title
The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Healthy blood donors or subjects who will get vaccinated.
You will not qualify if you...
- Known HIV infection
- Not a Swedish citizen
- Chronic liver or kidney disease
- Immunosuppression from treatment or disease
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Kalmar County Hospital
Kalmar, Sweden, 391 85
Actively Recruiting
2
Dept of Infectious Diseases
Linköping, Sweden, 581 85
Actively Recruiting
Research Team
T
Thomas Schoen, Professor
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here